Tesamorelin 12mg+Ipamorelin 6mg

Compound Overview

Research Use Only. Not for Human Consumption.

Tesamorelin 12mg+Ipamorelin 6mg is a Nexus-only multi-peptide research blend supplied as an 18mg lyophilized powder configuration. The source record identifies two listed components: Tesamorelin at 12mg and Ipamorelin at 6mg. Tesamorelin is listed as the GHRH analog component, and Ipamorelin is listed as the GHSR agonist component.

This product belongs to the Growth Hormone Secretagogues category and is listed under SKU TI18. The supplied chemistry record describes the item as a blend of tesamorelin and ipamorelin rather than as a single discrete molecular entity. For that reason, no single molecular formula, molecular weight, sequence, or CAS number applies to the complete product in the provided data.

The available factual record for this exact blend is intentionally limited. This page does not add unsupported chemistry, component sequences, molecular weights, CAS identifiers, formula data, purity percentages, COA results, batch numbers, literature claims, dosage language, human-use guidance, veterinary-use guidance, or therapeutic claims. Any component-level chemistry should be reviewed through validated individual component records rather than inferred from the blend name.

Research Background & Published Literature

The supplied research overview identifies TI18 as a Nexus-only GHRH/GHSR-pathway research blend. That classification is used here only to describe the pathway categories assigned to the two listed components in the source data. The record does not provide blend-specific experimental abstracts, peer-reviewed citations, assay concentrations, study models, endpoint summaries, or literature references for the exact 12mg+6mg configuration.

The only source listed in the supplied research data is the raw Nexus catalog record. No external literature source, component monograph, analytical worksheet, or lot-specific COA file is attached to this generated description.

Because no citations are supplied for this exact blend, no published literature claims are added to this description. Researchers evaluating the product should treat it as a blend record and separately assess the Tesamorelin and Ipamorelin component references using validated source material available to their laboratory.

The research file specifies that a Certificate of Analysis should verify both component identities and mass allocation. That distinction is important for a multi-peptide material: analytical review should confirm the presence and allocation of each named component rather than treating the product as one molecule with a single formula, single molecular weight, single sequence, or single CAS number.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Raun et al. (1998) — Eur J Endocrinol
• Matsumoto et al. (2001) — Biochem Biophys Res Commun
• Stanley et al. (2012) — Clin Infect Dis

Storage, Handling & Stability Guidelines

Store lyophilized Tesamorelin 12mg+Ipamorelin 6mg material at -20°C, desiccated, and protected from light. These are the storage conditions provided in the source record for this exact blend.

After reconstitution, aliquot the material and avoid repeated freeze-thaw cycles. The supplied data does not specify a reconstituted shelf life, diluent, concentration, temperature range after reconstitution, or validated stability interval, so those details should be controlled by laboratory SOPs and lot-specific documentation rather than inferred from this page.

• Maintain protection from moisture and light during storage and handling.
• Use aliquoting practices to reduce repeated freeze-thaw exposure after reconstitution.
• Do not assign a blend-level molecular weight, formula, CAS number, or sequence unless confirmed by validated source documentation.
• Retain internal records that identify the product name, SKU, total blend amount, component allocation, and reconstitution date when applicable.
• Handle the material only under appropriate in-vitro research procedures and institutional chemical-safety requirements.

Lab Verification

Nexus maintains a Lab Verified workflow for research materials. For this exact blend, the current product record does not include batch-specific COA attributes, normalized purity values, retention data, mass-found values, batch identifiers, analyst records, or test dates. No exact COA values are therefore stated on this page.

For a multi-peptide blend such as Tesamorelin 12mg+Ipamorelin 6mg, lab verification should address both component identities and mass allocation. In general terms, HPLC/MS verification can support chromatographic review and mass-spectrometry identity confirmation, but any exact result must come from the applicable batch COA rather than from a generated product description.

Researchers should use /lab-verified, the current product label, and applicable lot documentation as the controlling sources for batch-specific analytical details when those records are available.